In recent decades, the emphasis of biomarker research has centered around blood-based markers. However, blood biomarkers alone cannot capture the full spectrum of clinically relevant indicators.

Researchers have developed a more efficient way to find out which new 'designer drugs' are circulating in the community. In a new study, they showed how high-resolution mass spectrometry can be used ...

In recent decades, the emphasis of biomarker research has centered around blood-based markers. However, blood biomarkers alone cannot capture the full spectrum of clinically relevant indicators.